3rd Ubiquitin Research and Drug Discovery Conference
- 最後更新：
- 2013-02-08 06:11:41
- 活動時間：
- 2013-02-25 ~ 2013-02-26
- 活動地點：
- Las Vegas, NV, USA
- 報名時間：
- 0000-00-00 ~ 0000-00-00
- 活動費用：
- Register 3 people for the price of 2! Use discount code rcdvb.
活動介紹
This meeting will provide great opportunities to develop new ideas and network with experts in the ubiquitin-related drug discovery field. The new structural and regulatory insight on the largest enzyme family, E3 ligase, among the UPS pathways will shed light on the general and specific ways of targeting distinct ligases. Targeting DUBs associated with the proteasome will be the second largest pool of new UPS-related drug targets. What will be the next generation proteasome inhibitor?
Aaron Ciechanover, co-winner of the 2004 Nobel Prize in Chemistry will deliver the keynote address, "Intracellular Proteolysis and the Ubiquitin System: From the Backyard to the Center Stage of Biomedicine."
Preview the conference! Click here for an online look at the 3rd Ubiquitin Research and Drug Discovery Conference.
The 3rd Ubiquitin Research and Drug Discovery conference to be held in Las Vegas, NV on February 25-26, 2013, is part of the 2nd Novel Cancer Therapeutics Summit, which consists of this and two other tracks:
4th Cancer Targets and Therapeutics
2nd Oncology Partnering & Deal-Making
DISTINGUISHED SPEAKERS
Aaron Ciechanover, Nobel Laureate, Technion-Israel Institute of Technology - KEYNOTE
Raymond rofessor, Caltech, Investigator, Howard Hughes Medical Institute - FEATURED
Rachel Klevit, Professor, Biomolecular Structure Center, University of Washington - FEATURED
Tsui-Fen Chou, Assistant Professor, Harbor Medical Center UCLA
Yuan Chen, Professor, Molecular Medicine, Beckman Research Institute of City of Hope
Lawrence Dick, Director of Biochemistry, Millennium
Judith Frydman, Professor, Biology, Stanford University
David Fushman, Associate Professor, Department of Chemistry and Biochemistry, University of Maryland
Alfred Goldberg, Professor, Cell Biology, Harvard Medical School
Randy Hampton, Professor, Cell and Developmental Biology, UCSD
Chunhai 'Charlie' Hao, Associate Professor, Pathology & Laboratory Medicine, Emory University School of Medicine
Xavier Jacq, Head of Biology and Screening, MISSION Therapeutics
Jennifer Johnston, Vice President of Research, Elan Pharmaceuticals
Gary Kleiger, Assistant Professor, Biochemistry, University of Nevada, Las Vegas
Thimo Kurz, Programme Leader in Protein Ubiquitylation, Scottish Institute for Cell Signalling, College of Life Sciences, University of Dundee
Dustin McMinn, Associate Director, Medicinal Chemistry, Onyx Pharmaceuticals
Zhen-Qiang Pan, Professor, Oncological Sciences, Mount Sinai School of Medicine
Michael Rape, Associate Professor of Cell and Developmental Biology, University of California at Berkeley
Ingrid Wertz, Scientist, Genentech
David Wustrow, Vice President, Chemistry, Cleave Biosciences